Griesinger, F., Roeper, J., Pöttgen, C., Willborn, K. C., & Eberhardt, W. E. (2018). Brain metastases in ALK-positive NSCLC - time to adjust current treatment algorithms. Oncotarget, 9(80), 35181-35194. https://doi.org/10.18632/oncotarget.26073
Chicago Style (17th ed.) CitationGriesinger, Frank, Julia Roeper, Christoph Pöttgen, Kay C. Willborn, and Wilfried E.E Eberhardt. "Brain Metastases in ALK-positive NSCLC - Time to Adjust Current Treatment Algorithms." Oncotarget 9, no. 80 (2018): 35181-35194. https://doi.org/10.18632/oncotarget.26073.
MLA (9th ed.) CitationGriesinger, Frank, et al. "Brain Metastases in ALK-positive NSCLC - Time to Adjust Current Treatment Algorithms." Oncotarget, vol. 9, no. 80, 2018, pp. 35181-35194, https://doi.org/10.18632/oncotarget.26073.